(Q28368134)
Statements
The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients (English)
0 references
26
0 references
5-6
0 references
461-4
0 references